NM_020919.4(ALS2):c.4753_4754dup (p.Ser1585fs) AND Amyotrophic lateral sclerosis type 2, juvenile

Germline classification:: Likely pathogenic (1 submission)
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001250151.1

Allele description [Variation Report for NM_020919.4(ALS2):c.4753_4754dup (p.Ser1585fs)]

NM_020919.4(ALS2):c.4753_4754dup (p.Ser1585fs)

Gene:

ALS2:alsin Rho guanine nucleotide exchange factor ALS2 [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

2q33.1

Genomic location:

Preferred name:

NM_020919.4(ALS2):c.4753_4754dup (p.Ser1585fs)

HGVS:

NC_000002.12:g.201704538CT[3]
NC_000002.12:g.201704538_201704539dup
NG_008775.1:g.81632AG[3]
NM_020919.4:c.4753_4754dupMANE SELECT
NP_065970.2:p.Ser1585fs
LRG_654t1:c.4753_4754dup
LRG_654:g.81632AG[3]
LRG_654p1:p.Ser1585fs
NC_000002.11:g.202569261CT[3]
NM_020919.3:c.4753_4754dup

Protein change:

S1585fs

Links:

dbSNP: rs1689584119

NCBI 1000 Genomes Browser:

rs1689584119

Molecular consequence:

NM_020919.4:c.4753_4754dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Amyotrophic lateral sclerosis type 2, juvenile
Synonyms:: ALS, JUVENILE; Amyotrophic lateral sclerosis type 2
Identifiers:: MONDO: MONDO:0008780; MedGen: C1859807; Orphanet: 300605; OMIM: 205100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001424360	Centogene AG - the Rare Disease Company	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001424360

Centogene AG - the Rare Disease Company

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Centogene AG - the Rare Disease Company, SCV001424360.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 23, 2022

ClinVar

Relating variation to medicine